Search

Your search keyword '"Deroose, Christophe M."' showing total 642 results

Search Constraints

Start Over You searched for: Author "Deroose, Christophe M." Remove constraint Author: "Deroose, Christophe M."
642 results on '"Deroose, Christophe M."'

Search Results

1. Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0

7. How to attract young talent to nuclear medicine step 1: a survey conducted by the EANM Oncology and Theranostics Committee to understand the expectations of the next generation

9. Radiobiology of Combining Radiotherapy with Other Cancer Treatment Modalities

13. Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study

17. Clinical impact of using [18F]AlF‐NOTA‐octreotide PET/CT instead of [68Ga]Ga‐DOTA‐SSA PET/CT: Secondary endpoint analysis of a multicenter, prospective trial

18. Imaging standardisation in metastatic colorectal cancer: A joint EORTC-ESOI-ESGAR expert consensus recommendation

20. Standardised lesion segmentation for imaging biomarker quantitation: a consensus recommendation from ESR and EORTC

21. Value of [68Ga]Ga-somatostatin receptor PET/CT in the grading of pulmonary neuroendocrine (carcinoid) tumours and the detection of disseminated disease: single-centre pathology-based analysis and review of the literature

23. Radionuclide Therapy Management

24. Clinical impact of using [18F]AlF‐NOTA‐octreotide PET/CT instead of [68Ga]Ga‐DOTA‐SSA PET/CT: Secondary endpoint analysis of a multicenter, prospective trial.

25. Clinical management of typical and atypical carcinoids/neuroendocrine tumors in ENETS centres of excellence (CoE): Survey from the ENETS lung NET task force.

26. Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers

27. International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres

32. Impact of the COVID-19 crisis on imaging in oncological trials

39. Prospective comparison of [18F]AlF-NOTA-octreotide PET/MRI to [68Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients

41. Development and External Validation of a PET Radiomic Model for Prognostication of Head and Neck Cancer

48. Use and perceived utility of [18F]FDG PET/CT in neuroendocrine neoplasms: A consensus report from the European Neuroendocrine Tumor Society (ENETS) Advisory Board Meeting 2022.

50. Prospective comparison of [F-18]AlF-NOTA-octreotide PET/MRI to [Ga-68]Ga-DOTATATE PET/CT in neuroendocrine tumor patients

Catalog

Books, media, physical & digital resources